BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 15731241)

  • 1. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
    Lan K; Kuppers DA; Robertson ES
    J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.
    Liang Y; Chang J; Lynch SJ; Lukac DM; Ganem D
    Genes Dev; 2002 Aug; 16(15):1977-89. PubMed ID: 12154127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
    Lu J; Verma SC; Cai Q; Robertson ES
    J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between KSHV RTA and cellular RBP-Jkappa and their subsequent DNA binding are not sufficient for activation of RBP-Jkappa.
    Papugani A; Coleman T; Jones C; Zhang L
    Virus Res; 2008 Jan; 131(1):1-7. PubMed ID: 17850910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA.
    Wang Y; Yuan Y
    Virology; 2007 Mar; 359(1):19-27. PubMed ID: 17055026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
    Verma SC; Lan K; Choudhuri T; Robertson ES
    J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.
    Jin Y; He Z; Liang D; Zhang Q; Zhang H; Deng Q; Robertson ES; Lan K
    J Virol; 2012 May; 86(9):4956-69. PubMed ID: 22379075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.
    Liang Y; Ganem D
    J Virol; 2004 Jul; 78(13):6818-26. PubMed ID: 15194757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
    Carroll KD; Bu W; Palmeri D; Spadavecchia S; Lynch SJ; Marras SA; Tyagi S; Lukac DM
    J Virol; 2006 Oct; 80(19):9697-709. PubMed ID: 16973574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator.
    Izumiya Y; Izumiya C; Hsia D; Ellison TJ; Luciw PA; Kung HJ
    J Virol; 2009 May; 83(9):4435-46. PubMed ID: 19244329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome.
    Gonzalez-Lopez O; DeCotiis J; Goyeneche C; Mello H; Vicente-Ortiz BA; Shin HJ; Driscoll KE; Du P; Palmeri D; Lukac DM
    J Biol Chem; 2019 Aug; 294(35):13073-13092. PubMed ID: 31308175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.